BTIG sees upside across medtech stocks as iRhythm, Delcath and MiniMed stand out

More in Finance

• Windward Bio prices IPO at $17 per share on Nasdaq

  The biotechnology company has officially established terms for entering the public markets through an initial public offering. This move enables the firm to list its shares and open trading to institutional and retail investors on the Nasdaq exchange. The transaction establishes the company's opening valuation baseline as it transitions into a publicly traded entity.

  1 min read
• GPU Financing Filters Further Into ABS With Planned Newton Deal

  Equipment lenders are increasingly tapping public debt markets to fund surging demand for artificial intelligence hardware. Newton Commercial Finance is currently marketing a diversified collateral pool to investors that combines these specialized technology loans with traditional heavy industrial assets. The move illustrates how high-value computing infrastructure is rapidly becoming a standard component of institutional credit facilities.

  1 min read
• Why is LifeMD stock sliding today?

  Investor scrutiny has intensified as market participants seek to identify the catalyst driving the current downward pressure. The lack of an immediate public explanation leaves observers actively evaluating potential operational or broader sector influences. Further updates may clarify the exact fundamentals impacting trading sentiment.

  1 min read